Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
News|Articles|September 26, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-10-04-2017
- Volume 12
- Issue 10
Particle Analyzer Images Nanoparticles
The Nano-flow imaging particle analyzer from Fluid Imaging Technologies automatically image nanoparticles for identification.
The FlowCam Nano from Fluid Imaging Technologies reveals protein agglomerates, silicon oil droplets, glass shards, and other opaque, transparent, and translucent sub-visible particles with the high-resolution imagery needed for identification. The system uses a patented, oil immersion technology and provides digital images of particles ranging in size from 300 nm–30 µm.
Designed for analytical scientists, biochemists, and formulation scientists, the instrument was developed to find, expose, and identify nanoparticles in protein formulations and track the progression of protein agglomerates from individual, proteinaceous particles to the larger aggregates that can pose a threat to the safety, efficacy, stability, and longevity of parenteral bioformulations.
The company reports that the instrument may be used for USP <788> compliance testing methods for particulate matter by documenting the presence and type of nano-scale particles, which may cause failed test results.
Articles in this issue
about 9 years ago
Finding a New Purpose for an Unproven Drugabout 9 years ago
Demand for Efficiency Spurs Bioprocessing Innovationabout 9 years ago
Fresenius Kabi Breaks Ground on $250-Million Facility Expansionabout 9 years ago
UPS Reveals Supply Chain Security Systemabout 9 years ago
Cambrex Adds Reactors to Facility in Swedenabout 9 years ago
ADC Bio Invests $11 Million on Bioconjugation Facilityabout 9 years ago
Software Adds Data Integrity Functionsabout 9 years ago
Global Effort to Stop Sale of Illegal Drugs Advancesabout 9 years ago
BASF Plans Amine Facility in Nanjingabout 9 years ago
Eurofins Scientific to Acquire EAG LabsRelated to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.